To include your compound in the COVID-19 Resource Center, submit it here.
A double-blind, placebo-controlled, U.K. Phase I trial showed that oral ALB-127158(a) was well tolerated and
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury